These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 758781)

  • 21. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
    Gorsky JE; Latts JR
    Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoglycoside nephrotoxicity--a tale of two transports.
    Whelton A; Solez K
    J Lab Clin Med; 1982 Feb; 99(2):148-55. PubMed ID: 7038007
    [No Abstract]   [Full Text] [Related]  

  • 23. Extended dosage intervals for aminoglycosides.
    Rodman DP; Maxwell AJ; McKnight JT
    Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aminoglycoside antibiotics from a clinical viewpoint].
    Lüthy R
    Schweiz Med Wochenschr; 1976 Mar; 106(13):450-5. PubMed ID: 1265459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Number of serum drug concentration determinations influences costs of pharmacokinetic dosing programs.
    Millikan MD; Farnett LE
    Am J Hosp Pharm; 1987 Feb; 44(2):278, 282. PubMed ID: 3565381
    [No Abstract]   [Full Text] [Related]  

  • 26. Monitoring antimicrobial therapy.
    Sloan RW
    Am Fam Physician; 1982 Apr; 25(4):136-42. PubMed ID: 6461233
    [No Abstract]   [Full Text] [Related]  

  • 27. Aminoglycoside nephrotoxicity: recent developments.
    Walker R
    N Z Med J; 1994 Feb; 107(972):54-5. PubMed ID: 8115070
    [No Abstract]   [Full Text] [Related]  

  • 28. Aminoglycoside antibiotics: unsafe at any dose?
    MacDougall ML
    J Lab Clin Med; 1988 Dec; 112(6):669-70. PubMed ID: 3193022
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxicologic and pharmacologic considerations in the choice of empiric parenteral antibiotics.
    Glauser MP; Neftel KA
    Am J Med; 1986 May; 80(5C):64-9. PubMed ID: 3717190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aminoglygoside nephrotoxicity].
    Baykal M
    Mikrobiyol Bul; 1986 Jan; 20(1):32-6. PubMed ID: 3523171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting aminoglycoside nephrotoxicity.
    Moore RD; Smith CR; Lietman PS
    JAMA; 1986 Aug; 256(7):864-6. PubMed ID: 3735611
    [No Abstract]   [Full Text] [Related]  

  • 33. A possible mechanism for increased susceptibility to aminoglycoside nephrotoxicity in chronic renal disease.
    Riviere JE
    N Engl J Med; 1982 Jul; 307(4):252-3. PubMed ID: 7088081
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum monitoring and practicalities of once-daily aminoglycoside dosing.
    O'Shaughnessy EM; Das SS
    J Antimicrob Chemother; 1994 Feb; 33(2):350-1; author reply 351-2. PubMed ID: 8182019
    [No Abstract]   [Full Text] [Related]  

  • 35. Additive toxicity in patients receiving vancomycin and aminoglycosides.
    Rybak MJ; Boike SC
    Clin Pharm; 1983; 2(6):508. PubMed ID: 6653052
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic usefulness of aminoglycosides. Why netilmicin?].
    Bossa R
    Clin Ter; 1985 Nov; 115(3):201-4. PubMed ID: 4085177
    [No Abstract]   [Full Text] [Related]  

  • 37. Aminoglycosides: assessing the potential for nephrotoxicity.
    Wilson SE
    Surg Gynecol Obstet; 1990; 171 Suppl():24-30. PubMed ID: 2244292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of an acute kidney injury secondary to an implanted aminoglycoside.
    Wu IM; Marin EP; Kashgarian M; Brewster UC
    Kidney Int; 2009 May; 75(10):1109-12. PubMed ID: 18668023
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
    Dzierzanowska D; Nowik-Jurek M; Podleśny J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):389-94. PubMed ID: 6651487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do cephalosporins potentiate or antagonize aminoglycoside nephrotoxicity?
    Marsh FP
    J Antimicrob Chemother; 1978 Mar; 4(2):103-6. PubMed ID: 649529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.